Connect with us

Hi, what are you looking for?

Current News

Justin Bieber scraps world tour over health issues

Justin Bieber said Tuesday he is once again taking a break from touring, months after revealing he’d been diagnosed with a syndrome that caused him partial facial paralysis.

In June the 28-year-old megastar had pushed back the North American leg of his “Justice” tour due to Ramsay Hunt Syndrome, a complication of shingles.

Bieber recently went back on the road, performing six live shows in Europe as well as the Rock in Rio festival in Brazil this weekend.

But he said Tuesday his return to the stage had been premature.

“This past weekend I performed at Rock in Rio and I gave everything I have to the people in Brazil. After getting off stage, the exhaustion overtook me and I realized that I need to make my health the priority right now,” Bieber said.

“So I’m going to take a break from touring for the time being,” the “Peaches” singer continued. 

“I’m going to be OK, but I need time to rest and get better. I’ve been so proud to bring this show and our message of justice to the world.”

Ramsay Hunt Syndrome is a rare neurological disorder that can inflame and paralyze the facial nerve, and cause a painful rash around the ear or mouth. In addition to facial paralysis, it can cause hearing loss.

Bieber had dozens of performances across the globe scheduled through March 2023.

The superstar did not give an estimated timeline of recovery or indicate whether the “Justice” tour would ever resume.

Covid-19 had forced two postponements even before the singer’s health began suffering.

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...